Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194350 · ClinicalTrials.gov registry record
Factor V Leiden Mutation and Implantation Failure
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 399
- Enrollment target
NCT00194350: Completed study, sponsored by University of Pennsylvania.
NCT00194350 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 399 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194350 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 399 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific condition to be studied is the presence or absence of the Leiden mutation of the Factor V gene.
Interventions
- PROCEDURE Test for Factor V Leiden gene mutation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 399 participants |
| Start Date | 2001-09 |
| Est. Completion | 2005-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194350
The ClinicalTrials.gov registry entry for NCT00194350 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 399 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Test for Factor V Leiden gene mutation is the first listed.
NCT00194350 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194350 about?
NCT00194350 is a clinical study titled "Factor V Leiden Mutation and Implantation Failure". The purpose of this study is to determine whether inherited thrombophilias (tendency toward blood clotting) increase the risk of failure of the embryo to implant in IVF. The specific condition to be studied is the presence or absence of the Leiden mutation of the Factor V gene.
What is the current status of trial NCT00194350?
This trial is currently completed. The enrollment target is 399 participants. The study started on 2001-09. Estimated completion is 2005-08.
What interventions are being tested in trial NCT00194350?
The interventions under investigation include: Test for Factor V Leiden gene mutation (PROCEDURE).
Who is sponsoring clinical trial NCT00194350?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.